Skip to main content
. 2023 Feb 15;2023(2):CD011507. doi: 10.1002/14651858.CD011507.pub3

IRCT20120826010664N4.

Study name The effect of myoinositol supplementation on the prevention of gestational diabetes mellitus in high‐risk women
Methods Study type: randomised, multi‐center, clinical trial with parallel groups
Participants Inclusion criteria: BMI > 30, family history of type 2 diabetes, previous history of gestational diabetes, glucosoria, glucose metabolism disorder, and history of infant macrosomia.
Exclusion criteria: history of diabetes mellitus, multiple pregnancies, acute infection during pregnancy, impaired OGTT in first‐trimester routine tests.
Target sample size: 276 women
Interventions Intervention: 2 g of myo‐inositol + 200 mcg of folic acid twice per day from 14 to 28 weeks gestation.
Control: 200 mcg folic acid twice per day 
Outcomes Primary outcome: rate of gestational diabetes and other side effects of gestational diabetes
Starting date Expected recruitment start date: 20 February 2019
Contact information Dr Reihaneh Pirjani (Associate Professor)
Tehran University of Medical Sciences
pirjani@razi.tums.ac.ir
Notes The study is not blinded and it states that placebo is not used.
Registration date: 08 May 2019           
Last update: 08 May 2019